SEC Form 4 · accession 0001209191-15-017885
NOVAVAX INC · NVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A McManus Jr.
Director
Period of report
Feb 20, 2015
Accepted (ET)
Feb 24, 2015 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000694
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2015 | M | 15,000 | $1.48 | A | 92,590 | D | |
| Common Stock | Feb 20, 2015 | M | 15,000 | $2.61 | A | 107,590 | D | |
| Common Stock | Feb 20, 2015 | M | 15,000 | $2.35 | A | 122,590 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) | $1.48 | Feb 20, 2015 | M | 15,000 | D | Nov 4, 2005 | May 4, 2015 | Common Stock | 15,000 | 0 | D |
| Stock Option (Right to buy) | $2.61 | Feb 20, 2015 | M | 15,000 | D | Sep 6, 2008 | Mar 6, 2018 | Common Stock | 15,000 | 0 | D |
| Stock Option (Right to buy) | $2.35 | Feb 20, 2015 | M | 15,000 | D | Sep 15, 2010 | Mar 15, 2020 | Common Stock | 15,000 | 0 | D |